Holen Sie sich die Stockscreener-App
11.98
0.83%
-0.10
Handel nachbörslich:
12.10
0.12
+1.00%
Schlusskurs vom Vortag:
$12.08
Offen:
$12.12
24-Stunden-Volumen:
1.64M
Relative Volume:
0.99
Marktkapitalisierung:
$1.34B
Einnahmen:
$577.74M
Nettoeinkommen (Verlust:
$-149.78M
KGV:
-8.5571
EPS:
-1.4
Netto-Cashflow:
$-78.21M
1W Leistung:
-0.37%
1M Leistung:
+1.87%
6M Leistung:
-34.14%
1J Leistung:
-28.26%
1-Tages-Spanne:
$11.71
$12.15
1-Wochen-Bereich:
$11.71
$12.49
52-Wochen-Spanne:
$10.87
$34.13
Novocure Ltd Stock (NVCR) Company Profile
Firmenname
Novocure Ltd
Sektor
Branche
Telefon
44 (0)15 3475 6700
Adresse
NO. 4 THE FORUM, ST. HELIER
Vergleichen Sie NVCR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NVCR
Novocure Ltd
|
11.98 | 1.36B | 577.74M | -149.78M | -78.21M | -1.40 |
|
ABT
Abbott Laboratories
|
132.81 | 228.80B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.29 | 158.04B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.34 | 149.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.85 | 119.71B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.96 | 48.01B | 5.69B | 1.41B | 577.90M | 6.95 |
Novocure Ltd Stock (NVCR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-07-08 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2024-12-02 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-10-16 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2023-11-20 | Fortgesetzt | JP Morgan | Neutral |
| 2023-08-28 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2023-08-08 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-08-04 | Eingeleitet | SVB Securities | Outperform |
| 2023-07-31 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2023-06-07 | Hochstufung | Wedbush | Underperform → Neutral |
| 2023-05-16 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-03-17 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-01-06 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-01-05 | Bestätigt | H.C. Wainwright | Buy |
| 2022-11-29 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-10-24 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-07-05 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2022-05-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-02-08 | Eingeleitet | Loop Capital | Buy |
| 2022-02-02 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2022-01-20 | Hochstufung | Truist | Hold → Buy |
| 2022-01-03 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-07-01 | Herabstufung | Mizuho | Buy → Neutral |
| 2021-04-14 | Herabstufung | Wedbush | Neutral → Underperform |
| 2021-01-25 | Bestätigt | Piper Sandler | Overweight |
| 2020-09-23 | Eingeleitet | Northland Capital | Outperform |
| 2020-09-18 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-09-17 | Herabstufung | Truist | Buy → Hold |
| 2020-06-01 | Fortgesetzt | Oppenheimer | Perform |
| 2020-05-01 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-04-09 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-03-05 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-07-29 | Hochstufung | SunTrust | Hold → Buy |
| 2019-07-26 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-07-26 | Herabstufung | Wedbush | Outperform → Neutral |
| 2019-03-20 | Eingeleitet | SunTrust | Hold |
| 2018-11-02 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2018-07-16 | Eingeleitet | Evercore ISI | Outperform |
| 2018-04-18 | Bestätigt | Mizuho | Buy |
| 2018-02-23 | Bestätigt | Mizuho | Buy |
| 2017-05-24 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2016-07-29 | Bestätigt | Wedbush | Outperform |
| 2016-01-19 | Eingeleitet | Barclays | Underweight |
| 2015-12-02 | Eingeleitet | Deutsche Bank | Hold |
Alle ansehen
Novocure Ltd Aktie (NVCR) Neueste Nachrichten
Strategies to average down on NovoCure Limited2025 Trading Volume Trends & Growth-Oriented Investment Plans - Newser
Can NovoCure Limited recover in the next quarterTrend Reversal & Verified Technical Signals - Newser
What the charts say about NovoCure Limited today2025 AllTime Highs & Low Drawdown Investment Ideas - Newser
What to expect from NovoCure Limited in the next 30 daysTrade Ideas & Fast Exit and Entry Strategy Plans - Newser
Understanding NovoCure Limited’s price movementWeekly Stock Report & AI Enhanced Trade Execution Alerts - Newser
Is NovoCure Limited a top pick in the sectorJuly 2025 Summary & Daily Chart Pattern Signals - khodrobank.com
What machine learning models say about NovoCure LimitedMarket Growth Report & Breakout Confirmation Trade Signals - Newser
NovoCure (NVCR) Is Up 5.4% After Spain Reimburses TTFields Therapy—Has The Bull Case Changed? - Yahoo Finance
Is NovoCure Limited stock entering bullish territoryGap Up & Verified Entry Point Signals - Newser
How to forecast NovoCure Limited trends using time series2025 Market WrapUp & Stock Timing and Entry Methods - Newser
NovoCure Limited stock momentum explainedDip Buying & Reliable Entry Point Alerts - Newser
Identifying reversal signals in NovoCure LimitedTrade Volume Summary & Long-Term Growth Portfolio Plans - Newser
Price momentum metrics for NovoCure Limited explainedGap Down & Detailed Earnings Play Alerts - Newser
RSI Suggests Rebound May Be Near in NovoCure Limited getLinesFromResByArray error: size == 0 - 더경남뉴스
Nationwide Spanish Reimbursement for TTFields Could Be a Game Changer for NovoCure (NVCR) - simplywall.st
NovoCure Limited stock chart pattern explainedQuarterly Profit Report & Long-Term Investment Growth Plans - Newser
Using portfolio simulators with NovoCure Limited includedDollar Strength & Daily Profit Focused Screening - Newser
Using R and stats models for NovoCure Limited forecastingPortfolio Update Summary & AI Enhanced Trading Signals - Newser
Tools to assess NovoCure Limited’s risk profileAnalyst Upgrade & Momentum Based Trading Signals - Newser
NovoCure Limited Facing Inflection Point in Trend AnalysisWeekly Market Outlook & Risk Controlled Daily Plans - beatles.ru
Top chart patterns to watch in NovoCure Limited2025 EndofYear Setup & Consistent Income Trade Recommendations - Newser
2 Beaten-Down Stocks That Could Rocket 142% to 222% Higher, According to Wall Street Analysts - The Motley Fool
Analyzing recovery setups for NovoCure Limited investors2025 Top Decliners & Verified Swing Trading Watchlist - Newser
Multi asset correlation models including NovoCure LimitedWeekly Volume Report & Community Shared Stock Ideas - Newser
Finanzdaten der Novocure Ltd-Aktie (NVCR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Novocure Ltd-Aktie (NVCR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Stafford Kristin | Director |
Jun 03 '25 |
Sale |
17.28 |
999 |
17,259 |
3,054 |
| LEUNG GABRIEL | Director |
Jun 03 '25 |
Sale |
17.31 |
999 |
17,297 |
81,229 |
| Madden Martin J. | Director |
Jun 03 '25 |
Sale |
17.19 |
999 |
17,176 |
18,674 |
| Scannell Timothy J | Director |
Jun 03 '25 |
Sale |
17.32 |
999 |
17,299 |
6,018 |
| HILLEMAN JERYL L | Director |
Jun 03 '25 |
Sale |
17.26 |
999 |
17,247 |
5,591 |
| Ocean Allyson J | Director |
Jun 03 '25 |
Sale |
17.29 |
999 |
17,269 |
3,054 |
| VERNON W ANTHONY | Director |
Jun 03 '25 |
Sale |
17.35 |
999 |
17,329 |
167,887 |
| Hung David | Director |
Jun 03 '25 |
Sale |
17.30 |
999 |
17,280 |
12,195 |
| Leonard Frank X | EVP, Pres., Novocure Oncology |
Jun 02 '25 |
Sale |
17.50 |
30,196 |
528,413 |
168,452 |
0.38%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):